收稿日期: 2023-07-11
网络出版日期: 2023-12-11
基金资助
北京市卫生健康和科技成果适宜技术推广项目(BHTPP202053);首都临床特色诊疗技术研究及转化应用项目(Z221100007422040)
Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020
Received date: 2023-07-11
Online published: 2023-12-11
Supported by
Beijing Health Technologies Promotion Program(BHTPP202053);Beijing Municipal Commission of Science and Technology(Z221100007422040)
目的: 研究北京市慢性阻塞性肺疾病急性加重(acute exacerbation of chronic obstructive pulmonary disease, AECOPD)女性住院患者的流行病学特征及住院费用。方法: 选择2013—2020年北京市AECOPD女性患者的住院医保数据进行回顾性分析, 记录其年龄分布、合并症情况、住院时间、住院费用以及流行病学特征(时间和空间分布特点)。结果: 纳入166家医院57 911例住院患者, 平均年龄(78.84±8.59)岁, 80~89岁患者(49.06%)最多, 70~79岁(31.08%)次之, 18~50岁(0.41%)最少。合并冠心病、高血压以及心力衰竭的患者占比分别为30.60%、30.52%和26.54%。每日住院人次的中位数为18(IQR: 16), 且2013—2020年8年中总体呈增长趋势, 2015年开始明显增加, 上升趋势持续至2019年, 2020年则有所回落。冬春季住院人次占比(54.09%)高于夏秋季(45.91%)。各市辖区总住院人次占比排在前三位的分别为西城区(14.18%)、朝阳区(14.12%)和丰台区(13.47%); 城市西部、中心城区和东北部住院人次密度较高, 而近郊区住院人次密度则相对较低。AECOPD女性患者的住院时间和住院费用中位数分别为12 d和20 648.37元。城区患者的住院时间和住院费用均高于郊区, 差异有统计学意义(P<0.001)。西药费用是住院总费用的主要部分(33.32%)。研究时段住院费用总体呈先增长后降低随之趋于稳定的变化特征, 不同合并症患者的住院费用差异明显。结论: 北京市AECOPD女性住院患者以70岁及以上老年患者为主, 常合并心血管疾病, 主要在冬春季节发病且有地域差异, 其住院费用与患者年龄、合并症以及所在地区密切相关。
关键词: 慢性阻塞性肺疾病急性加重; 女性; 住院费用; 流行病学
王子恺 , 莫佳丽 , 张蒙 , 廖纪萍 . 2013—2020年北京市慢性阻塞性肺疾病急性加重女性住院患者的流行病学和住院费用分析[J]. 北京大学学报(医学版), 2023 , 55(6) : 1074 -1081 . DOI: 10.19723/j.issn.1671-167X.2023.06.019
Objective: To study epidemiological characteristics and hospitalization costs of female inpatients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Beijing. Methods: A retrospective study was conducted to analyze electronic hospitalization summary reports of female inpatients with AECOPD in Beijing from 2013 to 2020. Clinical characteristics (age distribution and comorbidities), epidemiological characteristics (temporal and spatial distribution characteristics), hospi-talization times and costs of patients were described. Results: A total of 57 911 subjects in 166 hospitals were included in this study, with a mean age of (78.84±8.59) years and the highest number of patients aged 80-89 years (49.06%), followed by patients aged 70-79 years (31.08%), and the lowest number of patients under 50 years (0.41%). The proportions of patients with coronary heart disease, hypertension and heart failure were 30.60%, 30.52% and 26.54% respectively. The median number of daily hospitalizations during the study period was 18 (IQR: 16). The number of daily hospitalizations for AECOPD showed an overall growth trend over the eight years from 2013 to 2020, starting to increase significantly in 2015 and continuing to increase until 2019, then followed by a decline in 2020. The proportion of inpatient admissions was higher in winter and spring (54.09%) than that in summer and autumn (45.91%). The top three districts in terms of the proportion of total inpatient admissions were Xicheng district (14.18%), Chaoyang district (14.12%) and Fengtai district (13.47%). The density of inpatients was relatively high in the western regions, central urban areas and northeastern regions of the city, while the density of inpatients was relatively low in the near suburbs. The median number of hospital days for female patients with AECOPD was 12 days, and the median hospital costs was CNY 20 648.37. Patients from urban areas had longer hospitalization times and higher hospitalization costs than those from suburban areas (P < 0.001). Western medicine expenses accounted for the largest proportion of total hospital expenses (33.32%). During the study period, hospitalization costs exhibited an overall pattern of initial growth, followed by subsequent decline, eventually stabilizing. The differences in hospitalization costs among the patients with different comorbidities were significant. Conclusion: Female hospitalized patients with AECOPD in Beijing were older than 70 years, often complicated by cardiovascular disease. AECOPD occurred mainly in winter and spring, with regional differences. The hospitalization costs were closely associated with the patients' age, comorbidities, and the geographicical region.
| 1 | Yin P , Wu J , Wang L , et al. The burden of COPD in China and its provinces: Findings from the global burden of disease study 2019[J]. Front Public Health, 2022, 10, 859499. |
| 2 | Cao Y , Xing Z , Long H , et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit[J]. Respir Res, 2021, 22 (1): 77. |
| 3 | Prediletto I , Giancotti G , Nava S . COPD exacerbation: Why it is important to avoid ICU admission[J]. J Clin Med, 2023, 12 (10): 3369. |
| 4 | Warwick M , Fernando SM , Aaron SD , et al. Outcomes and resource utilization among patients admitted to the intensive care unit following acute exacerbation of chronic obstructive pulmonary disease[J]. J Intensive Care Med, 2021, 36 (9): 1091- 1097. |
| 5 | Celli BR , Fabbri LM , Aaron SD , et al. Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: Best practice[J]. Am J Respir Crit Care Med, 2023, 207 (9): 1134- 1144. |
| 6 | Wu Y , Wang Z , Zheng Y , et al. Trends in Hospital admissions for chronic obstructive pulmonary diseases after comprehensive tobacco control policies in Beijing, China[J]. Nicotine Tob Res, 2022, 24 (12): 1978- 1984. |
| 7 | Scicluna V , Han M . COPD in women: future challenges[J]. Arch Bronconeumol, 2023, 59 (1): 3- 4. |
| 8 | Gao N , Li C , Ji J , et al. Short-term effects of ambient air pollution on chronic obstructive pulmonary disease admissions in Beijing, China (2013-2017)[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14, 297- 309. |
| 9 | Zysman M , Raherison-Semjen C . Women's COPD[J]. Front Med, 2021, 8, 600107. |
| 10 | Han MK , Postma D , Mannino DM , et al. Gender and chronic obstructive pulmonary disease: Why it matters[J]. Am J Respir Crit Care Med, 2007, 176 (12): 1179- 1184. |
| 11 | Bhatt SP , Bodduluri S , Nakhmani A , et al. Sex differences in airways at chest CT: Results from the COPD gene cohort[J]. Radiology, 2022, 305 (3): 699- 708. |
| 12 | Cheng LL , Liu YY , Su ZQ , et al. Clinical characteristics of tobacco smoke-induced versus biomass fuel-induced chronic obstructive pulmonary disease[J]. J Transl Int Med, 2015, 3 (3): 126- 129. |
| 13 | Kamal R , Srivastava AK , Kesavachandran CN , et al. Chronic obstructive pulmonary disease (COPD) in women due to indoor biomass burning: A meta analysis[J]. Int J Environ Health Res, 2022, 32 (6): 1403- 1417. |
| 14 | Xu M , Ke P , Wang C , et al. Cooking with biomass fuels and mortality among Chinese elderly people: A prospective cohort study[J]. Indoor Air, 2022, 32 (1): e12954. |
| 15 | Macdonald MI , Shafuddin E , King PT , et al. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease[J]. Lancet Respir Med, 2016, 4 (2): 138- 148. |
| 16 | Wang C , Xu J , Yang L , et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health[CPH] study): A national cross-sectional study[J]. Lancet, 2018, 391 (10131): 1706- 1717. |
| 17 | Rogliani P , Lauro D , Di Daniele N , et al. Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: A benefit of inhaled corticosteroids[J]. Expert Rev Respir Med, 2021, 15 (4): 561- 568. |
| 18 | Wang Z , Zhou Y , Luo M , et al. Association of diurnal temperature range with daily hospitalization for exacerbation of chronic respiratory diseases in 21 cities, China[J]. Respir Res, 2020, 21 (1): 251. |
| 19 | Radicioni G , Ceppe A , Ford AA , et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort[J]. Lancet Respir Med, 2021, 9 (11): 1241- 1254. |
| 20 | Li M , Chen S , Zhao H , et al. The short-term associations of chronic obstructive pulmonary disease hospitalizations with meteorological factors and air pollutants in Southwest China: A time-series study[J]. Sci Rep, 2021, 11 (1): 12914. |
| 21 | Liu Y, Han X, Cui X, et al. Association between air pollutants and acute exacerbation of chronic obstructive pulmonary disease: A time stratified case-crossover design with a distributed lag nonlinear model[J]. Geohealth, 2022, 6(2): e2021GH000529. |
| 22 | Zhang L , Zhao N , Zhang W , et al. Changes in long-term PM2.5 pollution in the urban and suburban areas of China's three largest urban agglomerations from 2000 to 2020[J]. Remote Sensing, 2022, 14 (7): 1716. |
| 23 | Jiang X , Xiao H , Segal R , et al. Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014[J]. Clin Ther, 2018, 40 (4): 613 e1- 626 e1. |
| 24 | Kim J , Lee TJ , Kim S , et al. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013[J]. J Med Econ, 2016, 19 (2): 103- 110. |
| 25 | Chen YH , Yao WZ , Cai BQ , et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Chin Med J (Engl), 2008, 121 (7): 587- 591. |
| 26 | Schermer TR , Hendriks AJ , Chavannes NH , et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice[J]. Prim Care Respir J, 2004, 13 (1): 48- 55. |
/
| 〈 |
|
〉 |